Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada-Reference-Cited by-同舟云学术

Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada

Published:2014 Issue:7 Volume:20 Page:721-730
ISSN:1359-6535
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Lepik Katherine J,Yip Benita,McGovern Rachel A,Ding Erin,Nohpal Adriana,Watson Birgit E,Toy Junine,Akagi Linda,Harrigan P Richard,Moore David M,Hogg Robert S,Montaner Julio SG,Barrios Rolando

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NiFe₂O₄@SiO₂@PrNH₂–DPA–CeCl₃: a cerium-based magnetic nano dual-acid catalyst with high efficacy and recyclability for domino sequential synthesis of lactam ring-fused 1,5-benzodiazepines;Catalysis Science & Technology;2023

2. Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan;BMC Infectious Diseases;2017-04-11

3. Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?;Expert Review of Anti-infective Therapy;2015-12-03

4. Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study;PLOS ONE;2015-10-14